Fisher & Paykel Healthcare Corporation Limited Share Price Börse Stuttgart

Equities

FPLB

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Delayed Börse Stuttgart 07:08:34 15/05/2024 BST 5-day change 1st Jan Change
15.6 EUR -0.64% Intraday chart for Fisher & Paykel Healthcare Corporation Limited 0.00% +20.77%

Financials

Sales 2024 * 1.73B 1.05B 970M 83.42B Sales 2025 * 1.94B 1.18B 1.09B 93.51B Capitalization 16.82B 10.19B 9.41B 810B
Net income 2024 * 257M 156M 144M 12.37B Net income 2025 * 331M 201M 185M 15.93B EV / Sales 2024 * 9.81 x
Net Debt 2024 * 179M 109M 100M 8.63B Net Debt 2025 * 235M 142M 131M 11.3B EV / Sales 2025 * 8.78 x
P/E ratio 2024 *
65.2 x
P/E ratio 2025 *
50.3 x
Employees -
Yield 2024 *
1.37%
Yield 2025 *
1.49%
Free-Float 91.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

Current month+0.64%
1 month+9.79%
3 months+18.94%
6 months+34.19%
Current year+20.77%
More quotes
1 week
15.60
Extreme 15.6
15.70
1 month
14.20
Extreme 14.2
16.30
3 years
10.20
Extreme 10.2
20.40
5 years
8.43
Extreme 8.427
22.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 31/12/84
Director of Finance/CFO - 28/02/19
Chief Tech/Sci/R&D Officer - 31/12/06
Members of the board TitleAgeSince
Director/Board Member 66 30/04/90
Chairman - 30/09/15
Chief Executive Officer 63 31/12/84
More insiders
Date Price Change
15/05/24 15.6 -0.64%
14/05/24 15.7 +0.64%
13/05/24 15.6 -0.64%
10/05/24 15.7 +0.64%
09/05/24 15.6 -0.64%

Delayed Quote Börse Stuttgart, May 15, 2024 at 07:08 am

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
28.8 NZD
Average target price
24.49 NZD
Spread / Average Target
-14.98%
Consensus